An updated clinical guideline from the American Society for Radiation Oncology (ASTRO) provides evidence-based ...
An international phase 3 clinical trial that treated patients with high-risk localized and locally advanced prostate cancer ...
An international phase 3 clinical trial that treated patients with high-risk localized and locally advanced prostate cancer ...
A 66-year-old man with prostate cancer had his tumor removed without the surgeon ever stepping into his operating room. Dr.
Dr. Kishore T. A , Senior Consultant, Uro Oncology & Transplant Surgery, Aster Medcity Kochi | A major 1,500-case experience ...
Johnson & Johnson (NYSE: JNJ) today announced new results from the Phase 3 PROTEUS substudy that directly compared the investigational use of apalutamide plus androgen deprivation therapy (ADT), given ...
Briganti and colleagues concluded that, together with the main PROTEUS study, the substudy supports 1-year perioperative apalutamide plus ADT as a treatment option for patients with high-risk ...
An international phase 3 clinical trial that treated patients with high-risk localized and locally advanced prostate cancer ...
New substudy results showed a 51% lower estimated risk of metastasis or death over time with perioperative apalutamide plus ...
Five-year results from the NRG-GU003 Phase III trial show that a 25-fraction, five-week postoperative radiation schedule ...
TRACE-I: Long-Term Outcomes of PSMA-Guided Salvage Surgery in Recurrent Prostate Cancer / cancer, cancer care, Cancer ...
The health benefits of prostate massage are based on very limited, and older, studies. They may improve prostatitis, an enlarged prostate, urinary hesitancy, or erectile dysfunction. 1. May Help With ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results